Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis

• 收藏
• 分享

专利权人:

Jan Nilsson

发明人:

Jan Nilsson

申请号：

US13569051

公开号：

US08435532B2

申请日:

2012.08.07

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention relates to the use of fibronectin, tenascin, collagens type I, III, VI and/or VIII modified by aldehyde or by glycosylation in ELISA for detection of antibodies in plasma and serum to diagnose atherosclerosis as well as the use of induction of tolerance and active as well as passive immunization against glycosylated or aldehydemodified fibronectin, tenascin, collagen type I, III, VI and/or VIII for prevention and treatment of atherosclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/